The Bioefficacy Protocol: biomarkers identification of TNF inhibitors efficacy in axial spondyloarthritis patients using transcriptome and proteome analysis.

MLA

Pinheiro Torres, R., et al. “The Bioefficacy Protocol: Biomarkers Identification of TNF Inhibitors Efficacy in Axial Spondyloarthritis Patients Using Transcriptome and Proteome Analysis.” ARP Rheumatology, vol. 3, no. 4, Oct. 2024, pp. 304–09. EBSCOhost, https://doi.org/10.63032/PREJ7967.

APA

Pinheiro Torres, R., Fernandes, A. F., Maia, S., Branco, J. C., Sobral, D., Varela Coelho, A., & Pimentel Santos, F. M. (2024). The Bioefficacy Protocol: biomarkers identification of TNF inhibitors efficacy in axial spondyloarthritis patients using transcriptome and proteome analysis. ARP Rheumatology, 3(4), 304–309. https://doi.org/10.63032/PREJ7967

Chicago

Pinheiro Torres, R., A. F. Fernandes, S. Maia, J. C. Branco, D. Sobral, A. Varela Coelho, and F. M. Pimentel Santos. 2024. “The Bioefficacy Protocol: Biomarkers Identification of TNF Inhibitors Efficacy in Axial Spondyloarthritis Patients Using Transcriptome and Proteome Analysis.” ARP Rheumatology 3 (4): 304–9. doi:10.63032/PREJ7967.